Cosmetic compositions and method of treating the skin
US-2019091122-A1 · Mar 28, 2019 · US
Compositions and methods for treating the eye
US10966948B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10966948-B2 |
| Application number | US-201916519166-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 23, 2019 |
| Priority date | Jul 23, 2019 |
| Publication date | Apr 6, 2021 |
| Grant date | Apr 6, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating the symptoms associated with dry eye, the method comprising the step of topically administering to a patient a composition comprising: i) a safe and effective amount of a compound and/or extract having retinol-like properties for treating dry eye and/or benefits for use in treating dry eye selected from one or more of: (a) one or more extracts from plants of the genera Acronychia, Licaria , and/or Trigonella; (b) one or more extracts of species of the genus Actinomyces ; and (c) one or more compounds of Formula (I): wherein— the dotted lines represent a single or double bond; R 1 represents an H, a carbon chain that is linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; R 2 represents a carbon chain that is linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; and A represents a carbon chain that is linear, cyclic, or branched, saturated or unsaturated, comprising from 1 to 20 carbon atoms; ii) one or more demulcent or soothing agents; and iii) optionally, an ophthalmologically acceptable carrier.
Assignees
Inventors
Classifications
Lauraceae (Laurel family), e.g. cinnamon or sassafras · CPC title
Inorganic compounds · CPC title
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae · CPC title
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title
Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10966948B2 cover?
- The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
- Who is the assignee on this patent?
- Johnson & Johnson Vision Care, Johnson & Johnson Surgical Vision Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/203. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).